Cargando…

The Interaction of Aging and Cellular Stress Contributes to Pathogenesis in Mouse and Human Huntington Disease Neurons

Huntington disease (HD) is a fatal, inherited neurodegenerative disorder caused by a mutation in the huntingtin (HTT) gene. While mutant HTT is present ubiquitously throughout life, HD onset typically occurs in mid-life. Oxidative damage accumulates in the aging brain and is a feature of HD. We soug...

Descripción completa

Detalles Bibliográficos
Autores principales:	Machiela, Emily, Jeloka, Ritika, Caron, Nicholas S., Mehta, Shagun, Schmidt, Mandi E., Baddeley, Helen J. E., Tom, Colton M., Polturi, Nalini, Xie, Yuanyun, Mattis, Virginia B., Hayden, Michael R., Southwell, Amber L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531251/ https://www.ncbi.nlm.nih.gov/pubmed/33192449 http://dx.doi.org/10.3389/fnagi.2020.524369

Ejemplares similares

Biological Aging and the Cellular Pathogenesis of Huntington’s Disease
por: Machiela, Emily, et al.
Publicado: (2020)

Optimization of trans-Splicing for Huntington's Disease RNA Therapy
por: Rindt, Hansjörg, et al.
Publicado: (2017)

Ultrasensitive measurement of huntingtin protein in cerebrospinal fluid demonstrates increase with Huntington disease stage and decrease following brain huntingtin suppression
por: Southwell, Amber L., et al.
Publicado: (2015)

Characterization of Neurodevelopmental Abnormalities in iPSC-Derived Striatal Cultures from Patients with Huntington’s Disease
por: Mathkar, Pranav P., et al.
Publicado: (2019)

Preventing mutant huntingtin proteolysis and intermittent fasting promote autophagy in models of Huntington disease
por: Ehrnhoefer, Dagmar E., et al.
Publicado: (2018)

Antisense Oligonucleotide Therapy: From Design to the Huntington Disease Clinic
por: Rook, Morgan E., et al.
Publicado: (2022)

Potent and sustained huntingtin lowering via AAV5 encoding miRNA preserves striatal volume and cognitive function in a humanized mouse model of Huntington disease
por: Caron, Nicholas S, et al.
Publicado: (2020)

Huntington’s Disease Patient-Derived Astrocytes Display Electrophysiological Impairments and Reduced Neuronal Support
por: Garcia, Veronica J., et al.
Publicado: (2019)

Striatal Synaptic Dysfunction and Hippocampal Plasticity Deficits in the Hu97/18 Mouse Model of Huntington Disease
por: Kolodziejczyk, Karolina, et al.
Publicado: (2014)

Design, Characterization, and Lead Selection of Therapeutic miRNAs Targeting Huntingtin for Development of Gene Therapy for Huntington's Disease
por: Miniarikova, Jana, et al.
Publicado: (2016)

A patient-derived cellular model for Huntington’s disease reveals phenotypes at clinically relevant CAG lengths
por: Hung, Claudia Lin-Kar, et al.
Publicado: (2018)

Mice lacking caspase-2 are protected from behavioral changes, but not pathology, in the YAC128 model of Huntington disease
por: Carroll, Jeffrey B, et al.
Publicado: (2011)

Microglial Activation in the Pathogenesis of Huntington’s Disease
por: Yang, Hui-Ming, et al.
Publicado: (2017)

Huntington’s Disease Pathogenesis: Two Sequential Components
por: Hong, Eun Pyo, et al.
Publicado: (2021)

DAPK1 Promotes Extrasynaptic GluN2B Phosphorylation and Striatal Spine Instability in the YAC128 Mouse Model of Huntington Disease
por: Schmidt, Mandi E., et al.
Publicado: (2020)

Multiple pathways contribute to the pathogenesis of Huntington disease
por: Li, Shihua, et al.
Publicado: (2006)

A Critical Review of White Matter Changes in Huntington’s Disease
por: Casella, Chiara, et al.
Publicado: (2020)

Altering cortical input unmasks synaptic phenotypes in the YAC128 cortico-striatal co-culture model of Huntington disease
por: Schmidt, Mandi E., et al.
Publicado: (2018)

Allele-Specific Suppression of Mutant Huntingtin Using Antisense Oligonucleotides: Providing a Therapeutic Option for All Huntington Disease Patients
por: Skotte, Niels H., et al.
Publicado: (2014)

Evaluation of Dimebon in cellular model of Huntington's disease
por: Wu, Jun, et al.
Publicado: (2008)

Soluble mutant huntingtin drives early human pathogenesis in Huntington’s disease
por: Miguez, Andrés, et al.
Publicado: (2023)

Transgenic animal models for study of the pathogenesis of Huntington’s disease and therapy
por: Chang, Renbao, et al.
Publicado: (2015)

Gut Bacteria Regulate the Pathogenesis of Huntington’s Disease in Drosophila Model
por: Chongtham, Anjalika, et al.
Publicado: (2022)

Targeting Mitochondrial Network Disorganization is Protective in C. elegans Models of Huntington’s Disease
por: Machiela, Emily, et al.
Publicado: (2021)

Structural and molecular myelination deficits occur prior to neuronal loss in the YAC128 and BACHD models of Huntington disease
por: Teo, Roy Tang Yi, et al.
Publicado: (2016)

Cerebrospinal fluid biomarkers for assessing Huntington disease onset and severity
por: Caron, Nicholas S, et al.
Publicado: (2022)

MicroRNAs Located in the Hox Gene Clusters Are Implicated in Huntington's Disease Pathogenesis
por: Hoss, Andrew G., et al.
Publicado: (2014)

The regulatory roles of microRNAs toward pathogenesis and treatments in Huntington's disease
por: Tung, Chih-Wei, et al.
Publicado: (2021)

Pathogenesis and potential therapeutic application of stem cells transplantation in Huntington’s disease
por: Saha, Sudeepto, et al.
Publicado: (2022)

Pathogenesis of Huntington’s Disease: An Emphasis on Molecular Pathways and Prevention by Natural Remedies
por: Irfan, Zainab, et al.
Publicado: (2022)

Corrigendum: Gut bacteria regulate the pathogenesis of Huntington's disease in Drosophila model
por: Chongtham, Anjalika, et al.
Publicado: (2022)

Mitochondria in Huntington’s disease: implications in pathogenesis and mitochondrial-targeted therapeutic strategies
por: Jurcau, Anamaria, et al.
Publicado: (2022)

Multi-compartment analysis of the complex gradient-echo signal quantifies myelin breakdown in premanifest Huntington's disease
por: Casella, Chiara, et al.
Publicado: (2021)

Indirect inhibition of 26S proteasome activity in a cellular model of Huntington’s disease
por: Hipp, Mark S., et al.
Publicado: (2012)

Gait Phase Estimation by Using LSTM in IMU-Based Gait Analysis—Proof of Concept
por: Sarshar, Mustafa, et al.
Publicado: (2021)

Skeletal Muscle Modulates Huntington’s Disease Pathogenesis in Mice: Role of Physical Exercise
por: Corrochano, Silvia, et al.
Publicado: (2018)

Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis
por: Onur, Tarik Seref, et al.
Publicado: (2021)

From Pathogenesis to Therapeutics: A Review of 150 Years of Huntington’s Disease Research
por: Jiang, Andrew, et al.
Publicado: (2023)

Myelin Breakdown in Human Huntington’s Disease: Multi-Modal Evidence from Diffusion MRI and Quantitative Magnetization Transfer
por: Bourbon-Teles, José, et al.
Publicado: (2019)

Gene expression profiles complement the analysis of genomic modifiers of the clinical onset of Huntington disease
por: Wright, Galen E B, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_iklb6qns259bneir1dv9b4na02